CN Patent

CN102438617A — 含有碱性添加剂的基质型缓释制剂

Assigned to Kyorin Pharmaceutical Co Ltd · Expires 2012-05-02 · 14y expired

What this patent protects

提供一种含有对酸不稳定的碱性药剂的医药组合物，其抑制作为主药的对酸不稳定的碱性药剂的分解，并且减轻了pH依赖性地释放。在含有对酸不稳定的碱性药剂的基质型缓释制剂中，加入水难溶性的碱性正盐。

USPTO Abstract

提供一种含有对酸不稳定的碱性药剂的医药组合物，其抑制作为主药的对酸不稳定的碱性药剂的分解，并且减轻了pH依赖性地释放。在含有对酸不稳定的碱性药剂的基质型缓释制剂中，加入水难溶性的碱性正盐。

Drugs covered by this patent

saxagliptin-hydrochloride (SAXAGLIPTIN HYDROCHLORIDE)

Patent Metadata

Patent number: CN102438617A
Jurisdiction: CN
Classification: —
Expires: 2012-05-02
Drug substance claim: No
Drug product claim: No
Assignee: Kyorin Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.